SIGLEC15 and head and neck squamous cell carcinoma: We also analyzed the expression levels of immune checkpoint markers in both HNSCC subtypes and found that the expression of CD274, HAVCR2, PDCD1LG2, and SIGLEC15 was elevated in cluster 2 (Figure 6G).